| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| BRISTOL MYERS SQUIBB | 4,593,158 | 9,817,080 |
| FATE THERAPEUTICS | 342,796 | 14,739 |
| FIBROGEN INC | 1,019,649 | 10,536 |
| GERON CORP | 59,000 | 26,400 |
| NEUROCRINE BIOSCIENCES | 5,612,539 | 17,445,090 |
| VOYAGER THERAPEUTICS | 90,778 | 58,950 |
| AMICUS THERAPEUTICS INC | 110,080 | 142,400 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL TAX PAYMENT | 17,500 | 0 | 0 |